Basic Study
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo
World J Gastrointest Pathophysiol
14(4):71-85.
Published online Aug 24, 2023.
doi: 10.4291/wjgp.v14.i4.71
Abstract (956)
|
Core Tip (1040)
|
Article Highlights (1052)
|
Full Article (HTML) (3437)
|
Figures (1-6) (564)
|
Tables (1-1) (624)
|
Full Article (PDF)-1730K (304)
|
Full Article with Cover (PDF)-1973K (230)
|
Full Article (XML)-137K (154)
|
Audio-875K (18)
|
Peer-Review Report-314K (146)
|
Answering Reviewers-148K (151)
|
Supplementary Material-220K (167)
|
Received: 06/01/2023
|
Revised: 08/02/2023
|
Accepted: 08/07/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (13145)
|
Similar Articles (0)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
